RFLNYSEPharmaceutical PreparationsFiscal year ends July 31
Rafael Holdings, Inc.
Financials through Q3 FY2026, quarter ended Apr 30, 2026Last filing: 10-Q on Jun 11, 2026
$1.29−0.10 (-7.19%)
Close on Oct 19, 2026
- Market cap
- $66.09M
- P/E (TTM)
- –
- Dividend yield
- –
Rafael Holdings, Inc. revenue by segment
By business segment
| Operating income | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q4 24 | TTM Q4 23 | TTM Q3 23 | TTM Q2 23 | TTM Q1 23 | TTM Q4 22 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Real Estate [Member] | $20.00K | $34.00K | $21.00K | -$50.00K | – | – | – | – | – | – | – | – | – |
| Infusion Technology [Member] | -$75.00K | -$127.00K | -$3.51M | -$3.82M | – | – | – | – | – | – | – | – | – |
| Healthcare [Member] | -$36.37M | -$35.38M | -$31.97M | -$25.29M | – | – | – | – | – | – | – | – | – |
By product or service
By region
From the segment and revenue-disaggregation notes of Rafael's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.